Skip to main content

Universitat Internacional de Catalunya

Desarrollo de Moléculas y Dispositivos Médicos

Desarrollo de Moléculas y Dispositivos Médicos
6
15191
1
Annual
OB
Main language of instruction: English

Other languages of instruction: Catalan, Spanish,

Teaching staff


Questions will be resolved before or after class.

Introduction

The subject shows the student the development process of biomedical products, including the development of drugs, medical devices, or digital products. Each of these different areas entails special particularities that will be analyzed throughout the subject.

Pre-course requirements

no prerequisites

Objectives

Understand the commercialization process of a drug, medical device, or digital device from its creation to the first sale.

Be able to develop the different stages of development of a biomedical technology.

Know the necessary language of the industry regarding development, value chain, markets, costs, and institutional relationships.

Competences/Learning outcomes of the degree programme

Basic skills:

CB1: That the student body demonstrates possession and understanding of knowledge in an area of study that is based on education in biomedical sciences and that involves knowledge from finance and business administration.

General competencies:

CG2: Integrate the basic concepts related to the biomedical industry both at a theoretical and work level.

CG6: Recognize basic concepts of different areas linked to the biomedical company.

Specific competencies:

CE9: Prepare a development plan for a health technology (drug, medical device, or digital device), the fictitious design of a clinical trial and plan the different phases of the process.

Learning outcomes of the subject

At the end of the course, the student:

Have acquired advanced knowledge in the different areas of the biomedical industry and the most used methodologies within companies.

Syllabus

Development of molecules and medical devices (5 ECTS)

- The value chain in the healthcare industry

- Development of health products

- Diagnostic products

- Development of biomedical devices

- Digital health and data management

- Creation of Spin-offs

- Advanced therapies

- CROs: Support for companies

- Industrialization and scaling

Teaching and learning activities

In person



• Master classes: Presentation of the contents of the subject orally by a teacher with secondary participation by the students.

• Conferences: Participation in a scientific or technical topic carried out by an expert in a specific subject. It will be related, in some way, to the sequencing of content of a certain subject, to ensure the integration of this type of teaching methodology in the subject in which it is located.

• Information search: Actively carried out by students, it is focused on the acquisition of knowledge autonomously, as well as training for the acquisition of skills and attitudes related to the need to obtain information in a discriminative way.

• Practical classes: Any activity developed through some type of professional technical procedure, always based on the conceptual contents of the master's degree and following its reasoning.

Evaluation systems and criteria

In person



Class participation and attitude: 20%

Multiple choice exam: 80%

General points to consider about the evaluation system:

You must attend at least 80% of the sessions to pass the subject.

You must obtain a 5 or more in the multiple-choice exam to pass the subject.

Participation in class is understood as the contribution of interesting ideas or the raising of pertinent questions that help improve the quality of the session.

Bibliography and resources

The Entrepreneur's Guide to a Biotech Startup. Peter Kolchinsky. www.evelexa.com. Free download:https://www.ctsi.ucla.edu/researcher  resources/files/view/docs/EGBS4_Kolchinsky.pdf


During the course, viewing videos that reinforce or introduce some content will be recommended. Those required viewing will be seen and discussed in class.